Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practice

Availability of novel hormonal therapies as well as docetaxel and cabazitaxel treatment for metastatic castration-resistant prostate cancer (CRPC) has changed the outlook for this group of patients with improvements in progression-free survival and overall survival. Physicians often diagnose the pro...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Asian J Androl
Auteurs principaux: Mizokami, Atsushi, Izumi, Kouji, Konaka, Hiroyuki, Kitagawa, Yasuhide, Kadono, Yoshifumi, Narimoto, Kazutaka, Nohara, Takahiro, Bahl, Amit K, Namiki, Mikio
Format: Artigo
Langue:Inglês
Publié: Medknow Publications & Media Pvt Ltd 2017
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5312209/
https://ncbi.nlm.nih.gov/pubmed/27270339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1008-682X.179159
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires